Findcure Biosciences (zhongshan) Co., Ltd.

This early-phase trial tests a new radioactive drug (177Lu-INN805) in 10 adults with advanced solid tumors like head & neck, thyroid, lung, breast, or sarcoma cancer who have not responded to standard treatments. The drug is given every 6 weeks for up to 4 cycles to find the safe…

This early-stage study tests a new radioactive drug called 177Lu-FC516 in 13 men with advanced prostate cancer that no longer responds to standard treatments. The main goals are to find the safest dose and check for side effects. Researchers will also look at whether the drug can…